- Home
- ACFN vs DRRX Comparison
ACFN vs DRRX Comparison
Compare ACFN & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- DRRX
- Stock Information
- Founded
- ACFN 1986
- DRRX 1998
- Country
- ACFN United States
- DRRX United States
- Employees
- ACFN N/A
- DRRX N/A
- Industry
- ACFN Military/Government/Technical
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- DRRX Health Care
- Exchange
- ACFN Nasdaq
- DRRX Nasdaq
- Market Cap
- ACFN 62.5M
- DRRX 59.3M
- IPO Year
- ACFN N/A
- DRRX 2000
- Fundamental
- Price
- ACFN $27.25
- DRRX $1.92
- Analyst Decision
- ACFN
- DRRX Hold
- Analyst Count
- ACFN 0
- DRRX 1
- Target Price
- ACFN N/A
- DRRX N/A
- AVG Volume (30 Days)
- ACFN 48.3K
- DRRX 3.1M
- Earning Date
- ACFN 08-07-2025
- DRRX 08-12-2025
- Dividend Yield
- ACFN N/A
- DRRX N/A
- EPS Growth
- ACFN 1520.82
- DRRX N/A
- EPS
- ACFN 2.84
- DRRX N/A
- Revenue
- ACFN $13,202,000.00
- DRRX $1,657,000.00
- Revenue This Year
- ACFN N/A
- DRRX N/A
- Revenue Next Year
- ACFN N/A
- DRRX $673.00
- P/E Ratio
- ACFN $9.61
- DRRX N/A
- Revenue Growth
- ACFN 50.98
- DRRX N/A
- 52 Week Low
- ACFN $17.22
- DRRX $0.48
- 52 Week High
- ACFN $33.00
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- DRRX 82.21
- Support Level
- ACFN N/A
- DRRX $1.86
- Resistance Level
- ACFN N/A
- DRRX $1.92
- Average True Range (ATR)
- ACFN 0.00
- DRRX 0.04
- MACD
- ACFN 0.00
- DRRX -0.03
- Stochastic Oscillator
- ACFN 0.00
- DRRX 90.00
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.